Stanford Medicine Experts Issue Stark Warning on Potency and Risks of Modern Cannabis for Older Adults

As a growing segment of the American population ages, a significant shift is occurring in cannabis consumption patterns. While many older adults are turning to marijuana products to manage chronic conditions like pain, insomnia, and anxiety, experts at Stanford Medicine are sounding an alarm: today’s cannabis is vastly more potent than the products widely available in previous decades, posing potentially serious and underappreciated health risks for this demographic. This evolving landscape necessitates a closer examination of the science, the user experience, and the medical implications for seniors navigating an increasingly complex cannabis market.

The Shifting Landscape of Cannabis and Aging

The rise in cannabis use among older Americans is not a sudden phenomenon but rather a continuation of broader trends that have accelerated with changing legal statuses and societal perceptions. For decades, marijuana was largely associated with younger generations. However, a confluence of factors—including the increasing legalization of both medical and recreational cannabis at the state level, a greater willingness among seniors to explore alternative therapies, and the persistent challenges of managing chronic conditions—has brought older adults into the cannabis conversation.

Eloise Theisen, a geriatric nurse practitioner specializing in cannabis therapy at Stanford Medicine, witnessed this trend firsthand. Her own journey with medical cannabis, initiated after a severe car accident left her with chronic pain unresponsive to conventional treatments, provided her with a unique perspective. Returning to work in an oncology clinic, she observed a significant number of patients either already using cannabis or contemplating its use, often without the benefit of professional medical guidance.

"I found that our patients were going to use it whether their providers approved of it or not," Theisen stated. "Many of our patients were older, and they had risks that needed to be evaluated and addressed before they started using cannabis." This realization underscored a critical gap in patient care and highlighted the urgent need for evidence-based information tailored to the specific needs and vulnerabilities of older adults.

Potency Surge: A New Era of Cannabis Strength

A central concern articulated by Stanford Medicine experts is the dramatic increase in the potency of cannabis products available today. For many older adults, their understanding of marijuana is likely rooted in experiences from the 1970s or 1980s, when typical THC (tetrahydrocannabinol) concentrations in cannabis flower hovered between 1% and 4%. This contrasts sharply with the current market. Legal cannabis flower now averages around 20% THC, with some strains reaching as high as 35%.

The disparity becomes even more pronounced when considering other product forms. Concentrates, oils, and edibles can boast THC levels approaching 90%. Furthermore, highly concentrated synthetic marijuana products, such as "spice" or "K2," which are illegal in California and many other states, are even more potent and have been linked to severe cardiovascular issues.

"We’re trying to catch up in our understanding of how that drastic of an increase in the psychoactive ingredient is impacting the brain and the body," commented Claudia Padula, PhD, an assistant professor of psychiatry and behavioral sciences at Stanford Medicine. This surge in potency means that a single dose of modern cannabis can deliver a significantly more intense psychoactive experience, increasing the likelihood of accidental overconsumption, particularly for individuals who may not be accustomed to such high concentrations.

This heightened potency has been directly linked to an increase in emergency room visits. A Canadian study examining emergency department data before and after nationwide cannabis legalization revealed a nearly threefold increase in cannabis poisoning cases among adults aged 65 and older. "There are so many different formulations and so many different strengths," emphasized Smita Das, MD, PhD, a clinical associate professor of psychiatry and behavioral sciences at Stanford Medicine. "This is really not the cannabis of the ’70s."

Cardiovascular and Cognitive Risks Magnified in Seniors

Beyond potency, Stanford Medicine experts are raising serious concerns about the potential cardiovascular and cognitive risks associated with regular cannabis use, especially for older adults. Heart disease remains the leading cause of death in the United States, making any substance that could exacerbate cardiovascular health a significant concern.

Joseph Wu, MD, PhD, director of the Stanford Cardiovascular Institute, pointed to research suggesting a link between regular cannabis use and cardiovascular disease. His team’s animal studies have indicated that THC can trigger inflammation in blood vessels. Epidemiological research in humans has further associated cannabis use with an increased risk of heart attacks (a 29% increase) and strokes (a 20% increase). While these risks may be lower than those associated with heavy tobacco or alcohol use, the reality for many older adults is the co-use of multiple substances. The synergistic effect of combining cannabis with cigarettes, alcohol, or both could amplify cardiovascular dangers.

Moreover, smoking cannabis has been implicated in an increased risk of lung cancer and cancers of the head and neck. Dr. Wu noted that smoking and vaping appear to promote more inflammation than edible products, though he cautioned that edibles are not without their own risks. "There is no safe amount of cannabis. Low doses and occasional use are still associated with vascular inflammation," he stated. "Abstinence is the safest option for heart health."

Cognitive health is another area of concern. Theisen observes that older patients using cannabis can experience complications such as dizziness, confusion, falls, and a worsening of pre-existing cognitive issues, including dementia. A key factor contributing to these risks is the slower metabolism of cannabis in older adults. This means the drug can remain in the body longer, extending its effects and increasing the potential for adverse reactions, particularly interactions with prescription medications.

One significant concern involves cannabidiol (CBD), a non-intoxicating cannabis compound. CBD can interfere with enzymes responsible for metabolizing medications, including blood thinners. This interference can elevate drug levels in the body, increasing the risk of bleeding. In some instances, cannabis compounds can also reduce the effectiveness of essential medications.

The Deceptive Nature of Cannabis Addiction

A pervasive myth suggests that cannabis is not addictive. However, Dr. Das counters this notion with research indicating that approximately 30% of regular cannabis users may develop cannabis use disorder. This condition is characterized by the drug’s significant impact on a person’s daily life, manifesting as withdrawal symptoms, a need for escalating doses, or interference with personal relationships and responsibilities.

While cannabis addiction rates are lower than those for alcohol, Dr. Das highlights a critical oversight: healthcare providers often do not routinely inquire about cannabis use among older adults. "I’m noticing that older adults may not necessarily be disclosing cannabis use to their providers unless specifically asked," she explained. "This isn’t a population we traditionally think about in terms of using cannabis."

For individuals struggling to reduce or cease their cannabis use, open communication with a doctor or addiction specialist is paramount. Therapies like cognitive behavioral therapy have demonstrated efficacy in treating substance use disorders. "Empowering individuals by helping them understand the criteria of a substance use disorder can then help them decide, ‘Is this something I want to talk about?’" Dr. Das elaborated. "On the clinician side, we can do a lot to make substance use part of the conversation. What are they using the cannabis for? And if somebody wants to stop using, we need to stick with them through the difficult part of stopping." Dr. Padula’s ongoing research using functional MRI scans is exploring how the brain reacts to environmental cues in individuals with cannabis use disorder, revealing heightened sensitivity to drug-related signals in those who relapse after treatment.

Navigating the Limited Evidence for Medical Benefits

While the legal and recreational use of cannabis continues to expand, the scientific consensus on its efficacy for various medical conditions, particularly among older adults, remains cautiously optimistic at best, with significant gaps in robust evidence. The Food and Drug Administration (FDA) has not approved cannabis itself for general medical treatment. However, it has approved two cannabis-related compounds: CBD for specific forms of childhood epilepsy and dronabinol, a synthetic cannabinoid, for treating nausea and appetite loss in patients undergoing chemotherapy or with HIV/AIDS.

Research has also shown benefits for muscle spasms associated with multiple sclerosis, a condition for which cannabis is approved in some countries, though not yet in the United States. The marketing of CBD products for a wide array of conditions, including pain, sleep disturbances, anxiety, and substance use disorders, often outpaces the availability of strong clinical evidence.

For chronic pain, a primary reason many seniors turn to cannabis, study findings are mixed. While some studies report pain relief, researchers have also observed substantial placebo effects. The American Psychiatric Association, with input from Dr. Das, has issued a statement opposing cannabis as a psychiatric treatment due to a lack of evidence demonstrating effectiveness for psychiatric disorders.

However, the perspective shifts for palliative care patients facing life-limiting illnesses. Eloise Theisen notes that many of these patients utilize cannabis to manage cancer-related symptoms, seeking alternatives to opioid medications, which carry risks of serious side effects and addiction. Research has indeed shown that chronic pain patients using cannabis sometimes reduce their opioid consumption. Furthermore, Theisen highlights the subjective benefits many patients experience, describing a sense of well-being and joy. "THC has gotten a bad rap over the years, but in very small doses it can be therapeutic," she stated. "There’s also a lot of stigma around its effects of euphoria. In our patients who may have months to a few years to live, still being able to experience joy is really important." This underscores a nuanced view where potential therapeutic benefits might exist in specific contexts and at low doses, particularly for symptom management and quality of life in terminal illness.

The Imperative of Honest Conversations with Healthcare Providers

Despite differing views on the extent of cannabis’s medical utility, Stanford Medicine experts universally agree on one crucial point: older adults must engage in open and honest conversations with their healthcare providers before using cannabis. Theisen strongly advocates for patients to seek guidance from medical professionals rather than relying on advice from dispensary staff or experimenting independently.

In the early years of legalization, Theisen frequently encountered patients who had accidentally consumed excessively high doses of THC edibles due to a lack of proper instructions. "Patients would sometimes end up in the emergency department, or they would not want to take it again because they thought, ‘This isn’t going to work for me,’" she recounted.

The difficulty in obtaining reliable, unbiased information about cannabis means that doctors play a vital role. They can assist patients in evaluating the appropriateness of cannabis for their specific needs, discuss potential alternatives, and identify risks related to existing medical conditions or medications.

"Your primary care physician will know the constellation of your medical conditions and other medications you might be on," Dr. Padula advised. "Talking to your doctor and letting them know not only what you’re prescribed, but what you’re using recreationally, will help formulate a way to do it in as safe a manner as possible." This collaborative approach is essential for ensuring that the increasing use of cannabis among older Americans is managed with an informed understanding of its potential benefits and significant risks. The ongoing research at Stanford Medicine aims to further illuminate these complex interactions, providing a clearer path forward for safe and effective patient care in this evolving landscape.